Cosmax (A192820) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
31 May, 2026Executive summary
Q1 2026 revenue reached 682.0 KRW bn, up 15.9% year-over-year, with operating profit at 53.0 KRW bn, up 3.3% YoY.
Korea led growth with diversified categories, China achieved record-high revenue, and the US began a turnaround.
Net profit surged 312.1% YoY to 43.8 KRW bn, driven by improved profitability in Korea and China and reduced losses in the US.
Financial highlights
Gross profit increased 9.7% YoY to 115.0 KRW bn, with a gross margin of 16.9%.
SG&A expenses rose 15.9% YoY to 62.0 KRW bn.
Non-operating profit turned positive at 2.4 KRW bn, aided by FX gains.
Net profit attributable to controlling shareholders rose 411.3% YoY to 41.6 KRW bn.
Outlook and guidance
Korea expected to maintain growth through ingredient-driven skincare and direct export expansion.
China to continue leveraging channel and client diversification for stable growth.
US region aims to sustain turnaround with strong order momentum and local indie brand partnerships.
Latest events from Cosmax
- H1 2024 revenue reached ₩1,078.3B with net income of ₩54.9B, led by Korea and Southeast Asia growth.A192820
Q2 202423 Jun 2026 - Q1 2025 revenue and operating profit grew, but net profit fell due to one-off and non-operating losses.A192820
Q1 202523 Jun 2026 - H1 2025 revenue hit KRW 1,212.1B, with net profit impacted by non-operating expenses.A192820
Q2 202523 Jun 2026 - Revenue up 1.0% YoY, but profit declined on one-off costs; R&D and ESG efforts remain strong.A192820
Q3 202523 Jun 2026 - Strong revenue and profit growth in 4Q 2025, led by health supplement and holding segments.A192820
Q4 20258 Mar 2026 - Korea and Southeast Asia drove robust profit growth, offsetting China and US weakness.A192820
Q3 202420 Feb 2026 - Record Q4 profit growth driven by Korea and Southeast Asia, with net profit turning positive.A192820
Q4 202420 Feb 2026